BSX financials
Boston Scientific (BSX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
BSX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $20.07B | $13.85B | $3.97B | $2.89B | 1.94 |
| 2024 | $16.75B | $10.27B | $2.63B | $1.85B | 1.25 |
| 2023 | $14.24B | $8.83B | $2.18B | $1.59B | 1.07 |
| 2022 | $12.68B | $7.71B | $1.82B | $698.00M | 0.45 |
| 2021 | $11.89B | $7.46B | $1.92B | $1.04B | 0.69 |
| 2020 | $9.91B | $5.58B | $601.00M | -$82.00M | -0.08 |
- BSX revenue was $20.07B in fiscal 2025, net income $2.89B.
Updated 2026-11-02 17:54 UTC